- Home
- KAVL vs BMRA Comparison
KAVL vs BMRA Comparison
Compare KAVL & BMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KAVL
- BMRA
- Stock Information
- Founded
- KAVL 1998
- BMRA 1971
- Country
- KAVL United States
- BMRA United States
- Employees
- KAVL N/A
- BMRA N/A
- Industry
- KAVL Medicinal Chemicals and Botanical Products
- BMRA Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- KAVL Health Care
- BMRA Health Care
- Exchange
- KAVL Nasdaq
- BMRA Nasdaq
- Market Cap
- KAVL 7.9M
- BMRA 8.1M
- IPO Year
- KAVL N/A
- BMRA N/A
- Fundamental
- Price
- KAVL $0.49
- BMRA $3.09
- Analyst Decision
- KAVL
- BMRA
- Analyst Count
- KAVL 0
- BMRA 0
- Target Price
- KAVL N/A
- BMRA N/A
- AVG Volume (30 Days)
- KAVL 26.0K
- BMRA 26.0K
- Earning Date
- KAVL 06-10-2025
- BMRA 04-14-2025
- Dividend Yield
- KAVL N/A
- BMRA N/A
- EPS Growth
- KAVL N/A
- BMRA N/A
- EPS
- KAVL N/A
- BMRA N/A
- Revenue
- KAVL $1,698,426.00
- BMRA $5,678,000.00
- Revenue This Year
- KAVL N/A
- BMRA N/A
- Revenue Next Year
- KAVL N/A
- BMRA N/A
- P/E Ratio
- KAVL N/A
- BMRA N/A
- Revenue Growth
- KAVL N/A
- BMRA 5.01
- 52 Week Low
- KAVL $0.46
- BMRA $1.93
- 52 Week High
- KAVL $1.95
- BMRA $10.16
- Technical
- Relative Strength Index (RSI)
- KAVL 36.05
- BMRA 45.39
- Support Level
- KAVL $0.52
- BMRA $3.03
- Resistance Level
- KAVL $0.56
- BMRA $3.44
- Average True Range (ATR)
- KAVL 0.03
- BMRA 0.19
- MACD
- KAVL -0.00
- BMRA 0.01
- Stochastic Oscillator
- KAVL 0.57
- BMRA 43.24
About KAVL Kaival Brands Innovations Group Inc.
Kaival Brands Innovations Group Inc is focused on growing and incubating innovative and profitable products. The company is engaged in the sale, marketing and distribution of electronic nicotine delivery system (ENDS) products and related components. Its primary product includes Bidi Stick. The BIDI Stick comes in a variety of flavor options for adult cigarette smokers.
About BMRA Biomerica Inc.
Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates in one segment namely, the design, development, marketing and sales of diagnostic kits. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America.